The use of antihypertensive drugs in patients with CKD was for angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) 86%, diuretics 55%, calcium channel blockers 27%, beta-blockers 27%, and alpha-blockers 5%. Here, ACE is linked to chronic kidney disease.